SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan -- Ignore unavailable to you. Want to Upgrade?


To: Kramer who wrote (345)8/14/1999 7:58:00 PM
From: Terry Lyon  Read Replies (1) | Respond to of 441
 
To me NEOG looks undervalued by comparison to peers in the biosciences. Only a small percentage of companies actually have earnings and are selling at a reasonable multiple. Still, I have questions about NEOG that I find I can't answer. Such questions as:

How many patents does NEOG own? Is field food testing a significant part of the future of food safety? Does anyone else compete head-to-head with NEOG - maybe IDXX? How will food irradiation effect the future of NEOG? Does NEOG have a hold on any particular technological field?

I appreciate your comments!